Clinical experience with recombinant human thyrotropin (rhTSH) in the follow-up of differentiated thyroid carcinoma

被引：0
|
作者：
Queiros, J. [1 ,2 ]
Neves, C. [1 ,3 ]
Carvalho, D. [1 ,3 ]
Lopes, F. [3 ]
Cavadinha, M. [3 ]
Veiga, F. [3 ]
Magalhaes, A. [1 ,2 ]
Medina, J. L. [1 ,3 ]
机构：
[1] Hosp Sao Joao, Oporto, Portugal
[2] Sch Med, Oporto, Portugal
[3] Hosp Sao Joao, Endocrinol Outpatient Clin, Oporto, Portugal
来源：
HORMONE RESEARCH | 2007年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid carcinoma
    Mcdougall, IR
    NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (10) : 871 - 873
  • [2] Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer
    Bombardieri, E
    Seregni, E
    Villano, C
    Aliberti, G
    Mattavelli, F
    TUMORI JOURNAL, 2003, 89 (05): : 533 - 536
  • [3] RECOMBINANT HUMAN THYROTROPIN VERSUS THYROID HORMONE WITHDRAWAL IN DIFFERENTIATED THYROID CARCINOMA FOLLOW-UP: A SINGLE CENTER EXPERIENCE
    Sahin, M.
    Aydogan, B., I
    Ozkan, E.
    Emral, R.
    Gullu, S.
    Erdogan, M. F.
    Corapcioglu, D.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (03)
  • [4] Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer
    Podoba, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 38 - 40
  • [5] Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer
    Durski, JM
    Weigel, RJ
    McDougall, IR
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) : 521 - 528
  • [6] Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma
    David, A
    Blotta, A
    Rossi, R
    Zatelli, MC
    Bondanelli, M
    Roti, E
    Braverman, LE
    Busutti, L
    degli Uberti, E
    THYROID, 2005, 15 (03) : 267 - 273
  • [7] Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma
    David, A
    Blotta, A
    Rossi, R
    Zatelli, MC
    Bondanelli, M
    Roti, E
    Braverman, LE
    Busutti, L
    degli Ubertil, EC
    THYROID, 2005, 15 (02) : 158 - 164
  • [8] The use of Recombinant Human Thyrotropin (rhTSH) in the Management of Differentiated Thyroid Cancer
    Skarulis M.C.
    Reviews in Endocrine and Metabolic Disorders, 2000, 1 (3) : 147 - 154
  • [9] The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer
    Basaria, M
    Graf, H
    Cooper, DS
    AMERICAN JOURNAL OF MEDICINE, 2002, 112 (09): : 721 - 725
  • [10] Follow-up of differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after recombinant human thyrotropin (rhTSH) or thyroid hormone withdrawal
    Elisei, R.
    Corone, C.
    Driedger, A.
    Haugen, B. R.
    Kloos, R. T.
    Magner, J.
    Pacini, F.
    Luster, M.
    Schlumberger, M.
    Sherman, S.
    Pinchera, A.
    Ladenson, P. W.
    HORMONE RESEARCH, 2007, 68 : 33 - 33
12345